Gordon Dunn
Chief Financial Officer
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2025-08-15
-
Start not stated–2025-08-15
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Quoin Pharmaceuticals Ltd. (QNRX) | Chief Financial Officer | $433,620 | $656,632 |
| 2023 | Quoin Pharmaceuticals Ltd. (QNRX) | Chief Financial Officer | $394,200 | $775,935 |
| 2022 | Quoin Pharmaceuticals Ltd. (QNRX) | Chief Financial Officer | $360,000 | $1,450,207 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.